3/7
12:54 pm
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $183.00 price target on the stock, up previously from $175.00.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $183.00 price target on the stock, up previously from $175.00.
3/7
12:54 pm
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $183.00 price target on the stock, up previously from $175.00.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $183.00 price target on the stock, up previously from $175.00.
3/7
12:36 pm
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
3/7
12:36 pm
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
3/7
09:17 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
3/7
08:17 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $179.00 price target on the stock, up previously from $145.00.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $179.00 price target on the stock, up previously from $145.00.
3/7
06:52 am
jazz
Jazz Pharmaceuticals upgraded to Buy from Neutral at UBS
Low
Report
Jazz Pharmaceuticals upgraded to Buy from Neutral at UBS
3/5
11:57 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $210.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $210.00 price target on the stock.
3/5
11:44 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
3/5
11:44 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/27
09:07 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/27
09:07 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/27
06:31 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Barclays PLC.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Barclays PLC.
2/26
05:39 pm
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/26
02:38 pm
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was downgraded by analysts at Cantor Fitzgerald from an "overweight" rating to a "neutral" rating.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was downgraded by analysts at Cantor Fitzgerald from an "overweight" rating to a "neutral" rating.
2/26
01:46 pm
jazz
Jazz Pharmaceuticals downgraded to Neutral from Overweight at Cantor Fitzgerald
Low
Report
Jazz Pharmaceuticals downgraded to Neutral from Overweight at Cantor Fitzgerald
2/26
11:55 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/26
11:55 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/26
11:04 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/26
06:10 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/26
06:10 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/13
08:12 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $170.00 price target on the stock, up previously from $130.00.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $170.00 price target on the stock, up previously from $130.00.
2/13
06:18 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/13
06:18 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/12
06:22 pm
jazz
Jazz Pharmaceuticals upgraded to Overweight from Equal Weight at Wells Fargo
Low
Report
Jazz Pharmaceuticals upgraded to Overweight from Equal Weight at Wells Fargo